definiens: shall mean, collectively, ( a ) Antibodies that bind to and aredirected against a Collaboration Antigen ( irrespective of whether such Collaboration Antigen becomes a DiscontinuedAntigen or a Failed Antigen ) ; ( b ) Genetic Materials that encode such Antibodies ; ( c ) amino acid sequences of suchAntibodies ; ( d ) Antibody Cells that contain, express or secrete such Antibodies or such Genetic Materials or suchamino acid sequences ; ( e ) uses of the foregoing or such Collaboration Antigen ; ( f ) inventions that uniquely relate tosuch Collaboration Antigen or one or more Antibodies or Antibody Equivalents that bind to and are directed againstsuch Collaboration Antigen ( including inventions specific to the function of such Collaboration Antigen in a particulardisease, state or condition, or the use of Antibodies or Antibody Equivalents to diagnose, prevent or treat suchdisease, state or condition, or the interaction of antibodies with such Collaboration Antigen, or assays or otherresearch or drug delivery tools specific to such Collaboration Antigen ) ; and ( g ) Information specifically regarding theforegoing or such Collaboration Antigen or Antibody Equivalents that bind to and are directed against suchCollaboration Antigen ; in each case ( of clauses ( a ) through ( g ) ) which are ( x ) Controlled by a Party as of the date thatsuch Collaboration Antigen is first designated as such ( other than any Information from any validation activitiesconducted by either Party or freedom to operate analyses conducted by AZ, in each case pursuant toSection 2.2.2(a ) ) or ( y ) first conceived or generated under or in connection with the Research Programs